SIMILAR PATTERNS OF AMINO ACIDS FOR 4Z91_F_4LEF401
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1c20 | DEAD RINGER PROTEIN (Drosophilamelanogaster) |
PF01388(ARID) | 4 | LEU A 87THR A 97LEU A 98THR A 92 | None | 0.77A | 4z91F-1c20A:undetectable4z91G-1c20A:undetectable4z91H-1c20A:undetectable4z91I-1c20A:undetectable4z91J-1c20A:undetectable | 4z91F-1c20A:19.464z91G-1c20A:19.464z91H-1c20A:19.464z91I-1c20A:19.464z91J-1c20A:19.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1del | DEOXYNUCLEOSIDEMONOPHOSPHATE KINASE (Escherichiavirus T4) |
no annotation | 4 | LEU A 6THR A 191THR A 237LEU A 238 | None | 0.80A | 4z91F-1delA:0.04z91G-1delA:0.04z91H-1delA:0.04z91I-1delA:0.04z91J-1delA:0.0 | 4z91F-1delA:20.624z91G-1delA:20.624z91H-1delA:20.624z91I-1delA:20.624z91J-1delA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1di6 | MOLYBDENUM COFACTORBIOSYNTHETIC ENZYME (Escherichiacoli) |
PF00994(MoCF_biosynth) | 4 | THR A 76THR A 88LEU A 89THR A 84 | SO4 A 201 (-2.8A)NoneNoneNone | 0.93A | 4z91F-1di6A:0.04z91G-1di6A:0.04z91H-1di6A:0.04z91I-1di6A:0.04z91J-1di6A:0.0 | 4z91F-1di6A:18.674z91G-1di6A:18.674z91H-1di6A:18.674z91I-1di6A:18.674z91J-1di6A:18.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dk5 | ANNEXIN 24(CA32) (Capsicum annuum) |
PF00191(Annexin) | 4 | LEU A 256THR A 265THR A 305LEU A 313 | None | 0.95A | 4z91F-1dk5A:0.24z91G-1dk5A:0.24z91H-1dk5A:0.34z91I-1dk5A:0.04z91J-1dk5A:0.3 | 4z91F-1dk5A:23.634z91G-1dk5A:23.634z91H-1dk5A:23.634z91I-1dk5A:23.634z91J-1dk5A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g5g | FUSION PROTEIN (Avianavulavirus 1) |
PF00523(Fusion_gly) | 4 | THR A 87LEU A 88THR A 218LEU A 217 | None | 0.90A | 4z91F-1g5gA:0.04z91G-1g5gA:0.04z91H-1g5gA:0.04z91I-1g5gA:0.04z91J-1g5gA:0.0 | 4z91F-1g5gA:21.984z91G-1g5gA:21.984z91H-1g5gA:21.984z91I-1g5gA:21.984z91J-1g5gA:21.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ig0 | THIAMINPYROPHOSPHOKINASE (Saccharomycescerevisiae) |
PF04263(TPK_catalytic)PF04265(TPK_B1_binding) | 4 | THR A 128THR A 208LEU A 209THR A 204 | None | 0.89A | 4z91F-1ig0A:0.04z91G-1ig0A:0.04z91H-1ig0A:0.04z91I-1ig0A:0.04z91J-1ig0A:0.0 | 4z91F-1ig0A:22.024z91G-1ig0A:22.024z91H-1ig0A:22.024z91I-1ig0A:22.024z91J-1ig0A:22.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ig0 | THIAMINPYROPHOSPHOKINASE (Saccharomycescerevisiae) |
PF04263(TPK_catalytic)PF04265(TPK_B1_binding) | 4 | THR A 208LEU A 209THR A 204THR A 128 | None | 0.88A | 4z91F-1ig0A:0.04z91G-1ig0A:0.04z91H-1ig0A:0.04z91I-1ig0A:0.04z91J-1ig0A:0.0 | 4z91F-1ig0A:22.024z91G-1ig0A:22.024z91H-1ig0A:22.024z91I-1ig0A:22.024z91J-1ig0A:22.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1n0w | DNA REPAIR PROTEINRAD51 HOMOLOG 1 (Homo sapiens) |
PF08423(Rad51) | 4 | LEU A 109THR A 143THR A 139LEU A 140 | None | 0.92A | 4z91F-1n0wA:0.04z91G-1n0wA:0.04z91H-1n0wA:0.04z91I-1n0wA:0.04z91J-1n0wA:0.0 | 4z91F-1n0wA:22.294z91G-1n0wA:22.294z91H-1n0wA:22.294z91I-1n0wA:22.294z91J-1n0wA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1pzn | DNA REPAIR ANDRECOMBINATIONPROTEIN RAD51 (Pyrococcusfuriosus) |
PF08423(Rad51)PF14520(HHH_5) | 4 | THR A 176THR A 173THR A 282THR A 145 | NoneNoneNoneSO4 A 350 (-3.5A) | 0.91A | 4z91F-1pznA:undetectable4z91G-1pznA:undetectable4z91H-1pznA:undetectable4z91I-1pznA:undetectable4z91J-1pznA:undetectable | 4z91F-1pznA:21.454z91G-1pznA:21.454z91H-1pznA:21.454z91I-1pznA:21.454z91J-1pznA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1pzn | DNA REPAIR ANDRECOMBINATIONPROTEIN RAD51 (Pyrococcusfuriosus) |
PF08423(Rad51)PF14520(HHH_5) | 4 | THR A 282THR A 145THR A 176THR A 173 | NoneSO4 A 350 (-3.5A)NoneNone | 0.91A | 4z91F-1pznA:undetectable4z91G-1pznA:undetectable4z91H-1pznA:undetectable4z91I-1pznA:undetectable4z91J-1pznA:undetectable | 4z91F-1pznA:21.454z91G-1pznA:21.454z91H-1pznA:21.454z91I-1pznA:21.454z91J-1pznA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q44 | STEROIDSULFOTRANSFERASE (Arabidopsisthaliana) |
PF00685(Sulfotransfer_1) | 4 | LEU A 136THR A 72THR A 78LEU A 81 | None | 0.85A | 4z91F-1q44A:undetectable4z91G-1q44A:undetectable4z91H-1q44A:undetectable4z91I-1q44A:undetectable4z91J-1q44A:undetectable | 4z91F-1q44A:20.114z91G-1q44A:20.114z91H-1q44A:20.114z91I-1q44A:20.114z91J-1q44A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q5a | EP-CADHERIN (Mus musculus) |
PF00028(Cadherin) | 4 | THR A 405THR A 407THR A 425LEU A 426 | NAG A 808 ( 4.5A)NAG A 808 (-2.2A)NDG A 811 (-2.2A)None | 0.96A | 4z91F-1q5aA:undetectable4z91G-1q5aA:undetectable4z91H-1q5aA:undetectable4z91I-1q5aA:undetectable4z91J-1q5aA:undetectable | 4z91F-1q5aA:16.504z91G-1q5aA:16.504z91H-1q5aA:16.504z91I-1q5aA:16.504z91J-1q5aA:16.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q5r | PROTEASOME BETA-TYPESUBUNIT 1 (Rhodococcuserythropolis) |
PF00227(Proteasome) | 4 | THR H 196LEU H 13THR H 210LEU H 213 | None | 0.87A | 4z91F-1q5rH:undetectable4z91G-1q5rH:undetectable4z91H-1q5rH:undetectable4z91I-1q5rH:undetectable4z91J-1q5rH:undetectable | 4z91F-1q5rH:19.784z91G-1q5rH:19.784z91H-1q5rH:19.784z91I-1q5rH:19.784z91J-1q5rH:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qo4 | PEROXIDASE (Arabidopsisthaliana) |
PF00141(peroxidase) | 4 | THR A 159LEU A 162THR A 252THR A 149 | None | 0.84A | 4z91F-1qo4A:undetectable4z91G-1qo4A:undetectable4z91H-1qo4A:undetectable4z91I-1qo4A:undetectable4z91J-1qo4A:undetectable | 4z91F-1qo4A:19.464z91G-1qo4A:19.464z91H-1qo4A:19.464z91I-1qo4A:19.464z91J-1qo4A:19.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qo4 | PEROXIDASE (Arabidopsisthaliana) |
PF00141(peroxidase) | 4 | THR A 252THR A 149THR A 159LEU A 162 | None | 0.91A | 4z91F-1qo4A:undetectable4z91G-1qo4A:undetectable4z91H-1qo4A:undetectable4z91I-1qo4A:undetectable4z91J-1qo4A:undetectable | 4z91F-1qo4A:19.464z91G-1qo4A:19.464z91H-1qo4A:19.464z91I-1qo4A:19.464z91J-1qo4A:19.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xco | PHOSPHATEACETYLTRANSFERASE (Bacillussubtilis) |
PF01515(PTA_PTB) | 4 | THR A 129THR A 149LEU A 137THR A 132 | UVW A 418 (-4.1A)NoneNoneNone | 0.89A | 4z91F-1xcoA:undetectable4z91G-1xcoA:undetectable4z91H-1xcoA:undetectable4z91I-1xcoA:undetectable4z91J-1xcoA:undetectable | 4z91F-1xcoA:21.204z91G-1xcoA:21.204z91H-1xcoA:21.204z91I-1xcoA:21.204z91J-1xcoA:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gau | TRANSCRIPTIONALREGULATOR, CRP/FNRFAMILY (Porphyromonasgingivalis) |
PF00027(cNMP_binding)PF13545(HTH_Crp_2) | 4 | LEU A 157THR A 228LEU A 210THR A 200 | None | 0.80A | 4z91F-2gauA:undetectable4z91G-2gauA:undetectable4z91H-2gauA:undetectable4z91I-2gauA:undetectable4z91J-2gauA:undetectable | 4z91F-2gauA:21.744z91G-2gauA:21.744z91H-2gauA:21.744z91I-2gauA:21.744z91J-2gauA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gau | TRANSCRIPTIONALREGULATOR, CRP/FNRFAMILY (Porphyromonasgingivalis) |
PF00027(cNMP_binding)PF13545(HTH_Crp_2) | 4 | LEU A 225THR A 200LEU A 157THR A 228 | None | 0.93A | 4z91F-2gauA:undetectable4z91G-2gauA:undetectable4z91H-2gauA:undetectable4z91I-2gauA:undetectable4z91J-2gauA:undetectable | 4z91F-2gauA:21.744z91G-2gauA:21.744z91H-2gauA:21.744z91I-2gauA:21.744z91J-2gauA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gp6 | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 2 (Mycobacteriumtuberculosis) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 4 | LEU A 64THR A 30LEU A 34THR A 26 | None | 0.85A | 4z91F-2gp6A:undetectable4z91G-2gp6A:undetectable4z91H-2gp6A:undetectable4z91I-2gp6A:undetectable4z91J-2gp6A:undetectable | 4z91F-2gp6A:20.694z91G-2gp6A:20.694z91H-2gp6A:20.694z91I-2gp6A:20.694z91J-2gp6A:20.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iab | HYPOTHETICAL PROTEIN (Streptomycesavermitilis) |
PF01243(Putative_PNPOx) | 4 | THR A 62LEU A 66LEU A 74THR A 30 | None | 0.82A | 4z91F-2iabA:undetectable4z91G-2iabA:undetectable4z91H-2iabA:undetectable4z91I-2iabA:undetectable4z91J-2iabA:undetectable | 4z91F-2iabA:17.734z91G-2iabA:17.734z91H-2iabA:17.734z91I-2iabA:17.734z91J-2iabA:17.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iq1 | PROTEIN PHOSPHATASE2C KAPPA, PPM1K (Homo sapiens) |
PF00481(PP2C) | 4 | THR A 296LEU A 295THR A 223LEU A 222 | None | 0.89A | 4z91F-2iq1A:undetectable4z91G-2iq1A:undetectable4z91H-2iq1A:undetectable4z91I-2iq1A:undetectable4z91J-2iq1A:undetectable | 4z91F-2iq1A:20.304z91G-2iq1A:20.304z91H-2iq1A:20.304z91I-2iq1A:20.304z91J-2iq1A:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jgd | 2-OXOGLUTARATEDEHYDROGENASE E1COMPONENT (Escherichiacoli) |
PF00676(E1_dh)PF02779(Transket_pyr)PF16870(OxoGdeHyase_C) | 4 | THR A 369LEU A 370THR A 353THR A 383 | None | 0.96A | 4z91F-2jgdA:undetectable4z91G-2jgdA:undetectable4z91H-2jgdA:undetectable4z91I-2jgdA:undetectable4z91J-2jgdA:undetectable | 4z91F-2jgdA:16.224z91G-2jgdA:16.224z91H-2jgdA:16.224z91I-2jgdA:16.224z91J-2jgdA:16.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2la7 | UNCHARACTERIZEDPROTEIN (Paraburkholderiaxenovorans) |
PF03724(META) | 4 | THR A 20LEU A 80THR A 26LEU A 56 | None | 0.87A | 4z91F-2la7A:undetectable4z91G-2la7A:undetectable4z91H-2la7A:undetectable4z91I-2la7A:undetectable4z91J-2la7A:undetectable | 4z91F-2la7A:17.704z91G-2la7A:17.704z91H-2la7A:17.704z91I-2la7A:17.704z91J-2la7A:17.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2na0 | GUANYLYLCYCLASE-ACTIVATINGPROTEIN 1 (Bos taurus) |
PF00036(EF-hand_1)PF13499(EF-hand_7) | 4 | THR A 169LEU A 170THR A 136LEU A 112 | None | 0.92A | 4z91F-2na0A:undetectable4z91G-2na0A:undetectable4z91H-2na0A:undetectable4z91I-2na0A:undetectable4z91J-2na0A:undetectable | 4z91F-2na0A:20.064z91G-2na0A:20.064z91H-2na0A:20.064z91I-2na0A:20.064z91J-2na0A:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oi6 | BIFUNCTIONAL PROTEINGLMU (Escherichiacoli) |
PF00132(Hexapep)PF12804(NTP_transf_3) | 4 | LEU A 102THR A 170THR A 113LEU A 117 | None | 0.96A | 4z91F-2oi6A:undetectable4z91G-2oi6A:undetectable4z91H-2oi6A:undetectable4z91I-2oi6A:undetectable4z91J-2oi6A:undetectable | 4z91F-2oi6A:22.324z91G-2oi6A:22.324z91H-2oi6A:22.324z91I-2oi6A:22.324z91J-2oi6A:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oqc | PENICILLIN V ACYLASE (Bacillussubtilis) |
PF02275(CBAH) | 4 | LEU A 116THR A 155THR A 5LEU A 15 | None | 0.96A | 4z91F-2oqcA:undetectable4z91G-2oqcA:undetectable4z91H-2oqcA:undetectable4z91I-2oqcA:undetectable4z91J-2oqcA:undetectable | 4z91F-2oqcA:22.744z91G-2oqcA:22.744z91H-2oqcA:22.744z91I-2oqcA:22.744z91J-2oqcA:22.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pzi | PROBABLESERINE/THREONINE-PROTEIN KINASE PKNG (Mycobacteriumtuberculosis) |
PF00069(Pkinase)PF16918(PknG_TPR)PF16919(PknG_rubred) | 4 | THR A 334LEU A 335THR A 330LEU A 261 | None | 0.91A | 4z91F-2pziA:1.74z91G-2pziA:1.84z91H-2pziA:0.54z91I-2pziA:1.94z91J-2pziA:0.5 | 4z91F-2pziA:18.134z91G-2pziA:18.134z91H-2pziA:18.134z91I-2pziA:18.134z91J-2pziA:18.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r1f | PREDICTEDAMINODEOXYCHORISMATELYASE (Escherichiacoli) |
PF02618(YceG) | 4 | LEU A 279THR A 273THR A 244THR A 210 | None | 0.96A | 4z91F-2r1fA:undetectable4z91G-2r1fA:undetectable4z91H-2r1fA:undetectable4z91I-2r1fA:undetectable4z91J-2r1fA:undetectable | 4z91F-2r1fA:20.614z91G-2r1fA:20.614z91H-2r1fA:20.614z91I-2r1fA:20.614z91J-2r1fA:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r1f | PREDICTEDAMINODEOXYCHORISMATELYASE (Escherichiacoli) |
PF02618(YceG) | 4 | THR A 136LEU A 137THR A 173LEU A 149 | None | 0.81A | 4z91F-2r1fA:undetectable4z91G-2r1fA:undetectable4z91H-2r1fA:undetectable4z91I-2r1fA:undetectable4z91J-2r1fA:undetectable | 4z91F-2r1fA:20.614z91G-2r1fA:20.614z91H-2r1fA:20.614z91I-2r1fA:20.614z91J-2r1fA:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ran | ANNEXIN V (Rattusnorvegicus) |
PF00191(Annexin) | 4 | LEU A 94THR A 103THR A 143LEU A 151 | None CA A 322 (-3.9A)NoneNone | 0.78A | 4z91F-2ranA:undetectable4z91G-2ranA:undetectable4z91H-2ranA:undetectable4z91I-2ranA:undetectable4z91J-2ranA:undetectable | 4z91F-2ranA:21.134z91G-2ranA:21.134z91H-2ranA:21.134z91I-2ranA:21.134z91J-2ranA:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rdg | SUPERANTIGEN-LIKEPROTEIN 11 (Staphylococcusaureus) |
PF02876(Stap_Strp_tox_C)PF09199(SSL_OB) | 4 | THR A 119LEU A 103THR A 117LEU A 141 | None | 0.82A | 4z91F-2rdgA:undetectable4z91G-2rdgA:undetectable4z91H-2rdgA:undetectable4z91I-2rdgA:undetectable4z91J-2rdgA:undetectable | 4z91F-2rdgA:19.454z91G-2rdgA:19.454z91H-2rdgA:19.454z91I-2rdgA:19.454z91J-2rdgA:19.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rik | TITIN (Oryctolaguscuniculus) |
PF07679(I-set) | 4 | THR A 58LEU A 59LEU A 62THR A 20 | None | 0.89A | 4z91F-2rikA:undetectable4z91G-2rikA:undetectable4z91H-2rikA:undetectable4z91I-2rikA:undetectable4z91J-2rikA:undetectable | 4z91F-2rikA:22.714z91G-2rikA:22.714z91H-2rikA:22.714z91I-2rikA:22.714z91J-2rikA:22.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2var | FRUCTOKINASE (Sulfolobussolfataricus) |
PF00294(PfkB) | 4 | LEU A 218THR A 163THR A 199LEU A 202 | None | 0.87A | 4z91F-2varA:undetectable4z91G-2varA:undetectable4z91H-2varA:undetectable4z91I-2varA:undetectable4z91J-2varA:undetectable | 4z91F-2varA:19.474z91G-2varA:19.474z91H-2varA:19.474z91I-2varA:19.474z91J-2varA:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vg8 | HYDROQUINONEGLUCOSYLTRANSFERASE (Arabidopsisthaliana) |
PF00201(UDPGT) | 5 | LEU A 395THR A 370THR A 214LEU A 218THR A 141 | None | 1.49A | 4z91F-2vg8A:undetectable4z91G-2vg8A:undetectable4z91H-2vg8A:undetectable4z91I-2vg8A:undetectable4z91J-2vg8A:undetectable | 4z91F-2vg8A:20.654z91G-2vg8A:20.654z91H-2vg8A:20.654z91I-2vg8A:20.654z91J-2vg8A:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z7x | TOLL-LIKE RECEPTOR2, VARIABLELYMPHOCYTE RECEPTORB (Eptatretusburgeri;Homo sapiens) |
PF11921(DUF3439)PF13855(LRR_8) | 4 | LEU A 377THR A 411LEU A 412THR A 408 | None | 0.96A | 4z91F-2z7xA:undetectable4z91G-2z7xA:undetectable4z91H-2z7xA:undetectable4z91I-2z7xA:undetectable4z91J-2z7xA:undetectable | 4z91F-2z7xA:20.114z91G-2z7xA:20.114z91H-2z7xA:20.114z91I-2z7xA:20.114z91J-2z7xA:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zuc | DNA REPAIR ANDRECOMBINATIONPROTEIN RADA (Sulfolobussolfataricus) |
PF08423(Rad51)PF14520(HHH_5) | 4 | THR A 152THR A 149THR A 254THR A 121 | None | 0.91A | 4z91F-2zucA:1.74z91G-2zucA:undetectable4z91H-2zucA:1.64z91I-2zucA:1.64z91J-2zucA:undetectable | 4z91F-2zucA:23.464z91G-2zucA:23.464z91H-2zucA:23.464z91I-2zucA:23.464z91J-2zucA:23.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zuc | DNA REPAIR ANDRECOMBINATIONPROTEIN RADA (Sulfolobussolfataricus) |
PF08423(Rad51)PF14520(HHH_5) | 4 | THR A 254THR A 121THR A 152THR A 149 | None | 0.91A | 4z91F-2zucA:1.74z91G-2zucA:undetectable4z91H-2zucA:1.64z91I-2zucA:1.64z91J-2zucA:undetectable | 4z91F-2zucA:23.464z91G-2zucA:23.464z91H-2zucA:23.464z91I-2zucA:23.464z91J-2zucA:23.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b1e | BETAC-S LYASE (Streptococcusanginosus) |
PF00155(Aminotran_1_2) | 4 | THR A 206LEU A 207THR A 235LEU A 291 | None | 0.94A | 4z91F-3b1eA:undetectable4z91G-3b1eA:undetectable4z91H-3b1eA:undetectable4z91I-3b1eA:undetectable4z91J-3b1eA:undetectable | 4z91F-3b1eA:21.844z91G-3b1eA:21.844z91H-3b1eA:21.844z91I-3b1eA:21.844z91J-3b1eA:21.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b43 | TITIN (Oryctolaguscuniculus) |
PF07679(I-set) | 4 | THR A 250LEU A 251LEU A 254THR A 212 | None | 0.96A | 4z91F-3b43A:undetectable4z91G-3b43A:undetectable4z91H-3b43A:undetectable4z91I-3b43A:undetectable4z91J-3b43A:undetectable | 4z91F-3b43A:19.614z91G-3b43A:19.614z91H-3b43A:19.614z91I-3b43A:19.614z91J-3b43A:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cgd | PYRIDINENUCLEOTIDE-DISULFIDEOXIDOREDUCTASE,CLASS I (Bacillusanthracis) |
PF02852(Pyr_redox_dim)PF07992(Pyr_redox_2) | 5 | LEU A 108THR A 272THR A 254LEU A 251THR A 85 | None | 1.35A | 4z91F-3cgdA:undetectable4z91G-3cgdA:undetectable4z91H-3cgdA:undetectable4z91I-3cgdA:undetectable4z91J-3cgdA:undetectable | 4z91F-3cgdA:20.294z91G-3cgdA:20.294z91H-3cgdA:20.294z91I-3cgdA:20.294z91J-3cgdA:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hpg | INTEGRASE (Visna-maedivirus) |
PF00665(rve)PF02022(Integrase_Zn) | 4 | THR A 159LEU A 160THR A 184THR A 163 | None | 0.96A | 4z91F-3hpgA:undetectable4z91G-3hpgA:undetectable4z91H-3hpgA:undetectable4z91I-3hpgA:undetectable4z91J-3hpgA:undetectable | 4z91F-3hpgA:18.584z91G-3hpgA:18.584z91H-3hpgA:18.584z91I-3hpgA:18.584z91J-3hpgA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hpg | INTEGRASE (Visna-maedivirus) |
PF00665(rve)PF02022(Integrase_Zn) | 4 | THR A 184THR A 163THR A 159LEU A 160 | None | 0.90A | 4z91F-3hpgA:undetectable4z91G-3hpgA:undetectable4z91H-3hpgA:undetectable4z91I-3hpgA:undetectable4z91J-3hpgA:undetectable | 4z91F-3hpgA:18.584z91G-3hpgA:18.584z91H-3hpgA:18.584z91I-3hpgA:18.584z91J-3hpgA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l4e | UNCHARACTERIZEDPEPTIDASE LMO0363 (Listeriamonocytogenes) |
PF03575(Peptidase_S51) | 4 | THR A 125LEU A 150THR A 89LEU A 92 | None | 0.82A | 4z91F-3l4eA:undetectable4z91G-3l4eA:undetectable4z91H-3l4eA:undetectable4z91I-3l4eA:undetectable4z91J-3l4eA:undetectable | 4z91F-3l4eA:20.724z91G-3l4eA:20.724z91H-3l4eA:20.724z91I-3l4eA:20.724z91J-3l4eA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lda | DNA REPAIR PROTEINRAD51 (Saccharomycescerevisiae) |
PF08423(Rad51)PF14520(HHH_5) | 4 | LEU A 167THR A 201THR A 197LEU A 198 | None | 0.94A | 4z91F-3ldaA:undetectable4z91G-3ldaA:undetectable4z91H-3ldaA:undetectable4z91I-3ldaA:undetectable4z91J-3ldaA:undetectable | 4z91F-3ldaA:22.754z91G-3ldaA:22.754z91H-3ldaA:22.754z91I-3ldaA:22.754z91J-3ldaA:22.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ly9 | TRANSCRIPTIONALACTIVATOR CADC (Escherichiacoli) |
no annotation | 4 | THR A 233THR A 229THR A 325LEU A 326 | None | 0.89A | 4z91F-3ly9A:2.94z91G-3ly9A:3.04z91H-3ly9A:1.94z91I-3ly9A:3.04z91J-3ly9A:2.1 | 4z91F-3ly9A:21.134z91G-3ly9A:21.134z91H-3ly9A:21.134z91I-3ly9A:21.134z91J-3ly9A:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ly9 | TRANSCRIPTIONALACTIVATOR CADC (Escherichiacoli) |
no annotation | 4 | THR A 325LEU A 326THR A 233THR A 229 | None | 0.88A | 4z91F-3ly9A:2.94z91G-3ly9A:3.04z91H-3ly9A:1.94z91I-3ly9A:3.04z91J-3ly9A:2.1 | 4z91F-3ly9A:21.134z91G-3ly9A:21.134z91H-3ly9A:21.134z91I-3ly9A:21.134z91J-3ly9A:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mde | MEDIUM CHAINACYL-COADEHYDROGENASE (Sus scrofa) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 4 | THR A 84LEU A 87THR A 102THR A 64 | None | 0.82A | 4z91F-3mdeA:3.24z91G-3mdeA:3.14z91H-3mdeA:2.44z91I-3mdeA:2.44z91J-3mdeA:3.2 | 4z91F-3mdeA:21.094z91G-3mdeA:21.094z91H-3mdeA:21.094z91I-3mdeA:21.094z91J-3mdeA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mde | MEDIUM CHAINACYL-COADEHYDROGENASE (Sus scrofa) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 4 | THR A 102THR A 64THR A 84LEU A 87 | None | 0.77A | 4z91F-3mdeA:3.24z91G-3mdeA:3.14z91H-3mdeA:2.44z91I-3mdeA:2.44z91J-3mdeA:3.2 | 4z91F-3mdeA:21.094z91G-3mdeA:21.094z91H-3mdeA:21.094z91I-3mdeA:21.094z91J-3mdeA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nv3 | GALECTIN 9 SHORTISOFORM VARIANT (Homo sapiens) |
PF00337(Gal-bind_lectin) | 4 | LEU A 318THR A 323THR A 197LEU A 310 | None | 0.83A | 4z91F-3nv3A:undetectable4z91G-3nv3A:undetectable4z91H-3nv3A:undetectable4z91I-3nv3A:undetectable4z91J-3nv3A:undetectable | 4z91F-3nv3A:18.404z91G-3nv3A:18.404z91H-3nv3A:18.404z91I-3nv3A:18.404z91J-3nv3A:18.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3okz | PUTATIVEUNCHARACTERIZEDPROTEIN GBS0355 (Streptococcusagalactiae) |
PF03816(LytR_cpsA_psr) | 4 | THR A 100LEU A 87THR A 98LEU A 318 | None | 0.91A | 4z91F-3okzA:undetectable4z91G-3okzA:undetectable4z91H-3okzA:undetectable4z91I-3okzA:undetectable4z91J-3okzA:undetectable | 4z91F-3okzA:20.824z91G-3okzA:20.824z91H-3okzA:20.824z91I-3okzA:20.824z91J-3okzA:20.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3onm | TRANSCRIPTIONALREGULATOR LRHA (Yersiniapseudotuberculosis) |
PF03466(LysR_substrate) | 4 | THR A 109LEU A 113THR A 154THR A 262 | None | 0.84A | 4z91F-3onmA:undetectable4z91G-3onmA:undetectable4z91H-3onmA:undetectable4z91I-3onmA:undetectable4z91J-3onmA:undetectable | 4z91F-3onmA:18.734z91G-3onmA:18.734z91H-3onmA:18.734z91I-3onmA:18.734z91J-3onmA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3onm | TRANSCRIPTIONALREGULATOR LRHA (Yersiniapseudotuberculosis) |
PF03466(LysR_substrate) | 4 | THR A 262THR A 109LEU A 113THR A 154 | None | 0.79A | 4z91F-3onmA:undetectable4z91G-3onmA:undetectable4z91H-3onmA:undetectable4z91I-3onmA:undetectable4z91J-3onmA:undetectable | 4z91F-3onmA:18.734z91G-3onmA:18.734z91H-3onmA:18.734z91I-3onmA:18.734z91J-3onmA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 4 | THR A 41THR A 120LEU A 121THR A 116 | None | 0.92A | 4z91F-3pocA:undetectable4z91G-3pocA:undetectable4z91H-3pocA:undetectable4z91I-3pocA:undetectable4z91J-3pocA:undetectable | 4z91F-3pocA:19.284z91G-3pocA:19.284z91H-3pocA:19.284z91I-3pocA:19.284z91J-3pocA:19.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3v9f | TWO-COMPONENT SYSTEMSENSOR HISTIDINEKINASE/RESPONSEREGULATOR, HYBRID(ONE-COMPONENTSYSTEM) (Bacteroidesthetaiotaomicron) |
PF07494(Reg_prop)PF07495(Y_Y_Y) | 4 | THR A 256THR A 260LEU A 251THR A 258 | None | 0.95A | 4z91F-3v9fA:undetectable4z91G-3v9fA:undetectable4z91H-3v9fA:undetectable4z91I-3v9fA:undetectable4z91J-3v9fA:undetectable | 4z91F-3v9fA:18.214z91G-3v9fA:18.214z91H-3v9fA:18.214z91I-3v9fA:18.214z91J-3v9fA:18.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wv6 | GALECTIN-9 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 4 | LEU A 318THR A 323THR A 197LEU A 310 | None | 0.72A | 4z91F-3wv6A:undetectable4z91G-3wv6A:undetectable4z91H-3wv6A:undetectable4z91I-3wv6A:undetectable4z91J-3wv6A:undetectable | 4z91F-3wv6A:22.544z91G-3wv6A:22.544z91H-3wv6A:22.544z91I-3wv6A:22.544z91J-3wv6A:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wv7 | HMD CO-OCCURRINGPROTEIN HCGE (Methanothermobactermarburgensis) |
PF00899(ThiF) | 4 | LEU A 180THR A 135THR A 114LEU A 115 | None | 0.94A | 4z91F-3wv7A:undetectable4z91G-3wv7A:undetectable4z91H-3wv7A:undetectable4z91I-3wv7A:undetectable4z91J-3wv7A:undetectable | 4z91F-3wv7A:23.104z91G-3wv7A:23.104z91H-3wv7A:23.104z91I-3wv7A:23.104z91J-3wv7A:23.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3x0f | CD81 ANTIGEN (Mus musculus) |
no annotation | 4 | LEU A 185THR A 168THR A 164LEU A 165 | NoneNoneNoneIPA A 301 ( 3.4A) | 0.92A | 4z91F-3x0fA:undetectable4z91G-3x0fA:undetectable4z91H-3x0fA:undetectable4z91I-3x0fA:undetectable4z91J-3x0fA:undetectable | 4z91F-3x0fA:13.644z91G-3x0fA:13.644z91H-3x0fA:13.644z91I-3x0fA:13.644z91J-3x0fA:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a0w | T-COMPLEX PROTEIN 1SUBUNIT BETA (Bos taurus) |
PF00118(Cpn60_TCP1) | 4 | THR A 29LEU A 30THR A 90THR A 87 | None | 0.96A | 4z91F-4a0wA:undetectable4z91G-4a0wA:undetectable4z91H-4a0wA:undetectable4z91I-4a0wA:undetectable4z91J-4a0wA:undetectable | 4z91F-4a0wA:20.684z91G-4a0wA:20.684z91H-4a0wA:20.684z91I-4a0wA:20.684z91J-4a0wA:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a5g | ANIONIC PEROXIDASE (Raphanussativus) |
PF00141(peroxidase) | 4 | THR A 161LEU A 164THR A 254THR A 151 | None | 0.83A | 4z91F-4a5gA:undetectable4z91G-4a5gA:undetectable4z91H-4a5gA:undetectable4z91I-4a5gA:undetectable4z91J-4a5gA:1.3 | 4z91F-4a5gA:19.534z91G-4a5gA:19.534z91H-4a5gA:19.534z91I-4a5gA:19.534z91J-4a5gA:19.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a5g | ANIONIC PEROXIDASE (Raphanussativus) |
PF00141(peroxidase) | 4 | THR A 254THR A 151THR A 161LEU A 164 | None | 0.90A | 4z91F-4a5gA:undetectable4z91G-4a5gA:undetectable4z91H-4a5gA:undetectable4z91I-4a5gA:undetectable4z91J-4a5gA:1.3 | 4z91F-4a5gA:19.534z91G-4a5gA:19.534z91H-4a5gA:19.534z91I-4a5gA:19.534z91J-4a5gA:19.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bx9 | VACUOLAR PROTEINSORTING-ASSOCIATEDPROTEIN 33A (Homo sapiens) |
PF00995(Sec1) | 4 | THR A 469LEU A 470THR A 465LEU A 518 | None | 0.96A | 4z91F-4bx9A:4.64z91G-4bx9A:4.44z91H-4bx9A:4.44z91I-4bx9A:4.54z91J-4bx9A:2.1 | 4z91F-4bx9A:20.924z91G-4bx9A:20.924z91H-4bx9A:20.924z91I-4bx9A:20.924z91J-4bx9A:20.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4da1 | PROTEIN PHOSPHATASE1K, MITOCHONDRIAL (Homo sapiens) |
PF00481(PP2C) | 4 | THR A 296LEU A 295THR A 223LEU A 222 | None | 0.87A | 4z91F-4da1A:undetectable4z91G-4da1A:undetectable4z91H-4da1A:undetectable4z91I-4da1A:undetectable4z91J-4da1A:undetectable | 4z91F-4da1A:21.634z91G-4da1A:21.634z91H-4da1A:21.634z91I-4da1A:21.634z91J-4da1A:21.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4frw | POLIOVIRUSRECEPTOR-RELATEDPROTEIN 4 (Homo sapiens) |
PF07686(V-set)PF08205(C2-set_2) | 4 | LEU A 210THR A 191THR A 185LEU A 221 | None | 0.96A | 4z91F-4frwA:undetectable4z91G-4frwA:3.44z91H-4frwA:undetectable4z91I-4frwA:undetectable4z91J-4frwA:undetectable | 4z91F-4frwA:23.234z91G-4frwA:23.234z91H-4frwA:23.234z91I-4frwA:23.234z91J-4frwA:23.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4igl | YENBYENC2 (Yersiniaentomophaga) |
PF03534(SpvB)PF12255(TcdB_toxin_midC)PF12256(TcdB_toxin_midN)no annotation | 4 | LEU B 90THR B 121THR A1105LEU A1109 | None | 0.88A | 4z91F-4iglB:undetectable4z91G-4iglB:undetectable4z91H-4iglB:undetectable4z91I-4iglB:undetectable4z91J-4iglB:undetectable | 4z91F-4iglB:18.984z91G-4iglB:18.984z91H-4iglB:18.984z91I-4iglB:18.984z91J-4iglB:18.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4je5 | AROMATIC/AMINOADIPATE AMINOTRANSFERASE 1 (Saccharomycescerevisiae) |
PF00155(Aminotran_1_2) | 5 | THR A 348LEU A 349THR A 341THR A 311LEU A 313 | None | 1.19A | 4z91F-4je5A:undetectable4z91G-4je5A:undetectable4z91H-4je5A:undetectable4z91I-4je5A:undetectable4z91J-4je5A:undetectable | 4z91F-4je5A:20.504z91G-4je5A:20.504z91H-4je5A:20.504z91I-4je5A:20.504z91J-4je5A:20.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4krt | AUTOLYTIC LYSOZYME (Clostridiumphage phiSM101) |
PF01183(Glyco_hydro_25)PF08239(SH3_3) | 4 | LEU A 100THR A 136THR A 114LEU A 113 | None | 0.96A | 4z91F-4krtA:undetectable4z91G-4krtA:undetectable4z91H-4krtA:undetectable4z91I-4krtA:undetectable4z91J-4krtA:undetectable | 4z91F-4krtA:21.244z91G-4krtA:21.244z91H-4krtA:21.244z91I-4krtA:21.244z91J-4krtA:21.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kru | AUTOLYTIC LYSOZYME (Clostridiumphage phiSM101) |
PF01183(Glyco_hydro_25) | 4 | LEU A 100THR A 136THR A 114LEU A 113 | None | 0.92A | 4z91F-4kruA:undetectable4z91G-4kruA:undetectable4z91H-4kruA:undetectable4z91I-4kruA:undetectable4z91J-4kruA:undetectable | 4z91F-4kruA:20.714z91G-4kruA:20.714z91H-4kruA:20.714z91I-4kruA:20.714z91J-4kruA:20.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mdv | ANNEXIN (Schistosomamansoni) |
PF00191(Annexin) | 4 | LEU A 45THR A 54THR A 94LEU A 102 | None CA A 401 ( 4.7A)NoneNone | 0.96A | 4z91F-4mdvA:undetectable4z91G-4mdvA:undetectable4z91H-4mdvA:undetectable4z91I-4mdvA:undetectable4z91J-4mdvA:undetectable | 4z91F-4mdvA:21.774z91G-4mdvA:21.774z91H-4mdvA:21.774z91I-4mdvA:21.774z91J-4mdvA:21.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nmw | PIMELYL-[ACYL-CARRIER PROTEIN] METHYLESTER ESTERASE (Salmonellaenterica) |
PF00561(Abhydrolase_1) | 4 | LEU A 202THR A 226THR A 251LEU A 252 | None | 0.82A | 4z91F-4nmwA:undetectable4z91G-4nmwA:undetectable4z91H-4nmwA:undetectable4z91I-4nmwA:undetectable4z91J-4nmwA:undetectable | 4z91F-4nmwA:21.454z91G-4nmwA:21.454z91H-4nmwA:21.454z91I-4nmwA:21.454z91J-4nmwA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oxx | CINDOXIN (Citrobacterbraakii) |
PF00258(Flavodoxin_1) | 4 | THR A 74LEU A 75THR A 40THR A 78 | None | 0.92A | 4z91F-4oxxA:undetectable4z91G-4oxxA:undetectable4z91H-4oxxA:undetectable4z91I-4oxxA:undetectable4z91J-4oxxA:undetectable | 4z91F-4oxxA:20.064z91G-4oxxA:20.064z91H-4oxxA:20.064z91I-4oxxA:20.064z91J-4oxxA:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oxx | CINDOXIN (Citrobacterbraakii) |
PF00258(Flavodoxin_1) | 4 | THR A 78THR A 74LEU A 75THR A 40 | None | 0.91A | 4z91F-4oxxA:undetectable4z91G-4oxxA:undetectable4z91H-4oxxA:undetectable4z91I-4oxxA:undetectable4z91J-4oxxA:undetectable | 4z91F-4oxxA:20.064z91G-4oxxA:20.064z91H-4oxxA:20.064z91I-4oxxA:20.064z91J-4oxxA:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wky | BETA-KETOACYLSYNTHASE (Streptomycesalbus) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C)PF16197(KAsynt_C_assoc) | 4 | THR A 495LEU A 496THR A 487LEU A 481 | None | 0.80A | 4z91F-4wkyA:undetectable4z91G-4wkyA:undetectable4z91H-4wkyA:undetectable4z91I-4wkyA:undetectable4z91J-4wkyA:undetectable | 4z91F-4wkyA:19.104z91G-4wkyA:19.104z91H-4wkyA:19.104z91I-4wkyA:19.104z91J-4wkyA:19.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y0x | SERINE/THREONINE-PROTEIN KINASE PKNG (Mycobacteriumtuberculosis) |
PF00069(Pkinase)PF16919(PknG_rubred) | 4 | THR A 334LEU A 335THR A 330LEU A 261 | None | 0.90A | 4z91F-4y0xA:undetectable4z91G-4y0xA:undetectable4z91H-4y0xA:undetectable4z91I-4y0xA:undetectable4z91J-4y0xA:undetectable | 4z91F-4y0xA:20.994z91G-4y0xA:20.994z91H-4y0xA:20.994z91I-4y0xA:20.994z91J-4y0xA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zkt | BOTULINUM NEUROTOXINTYPE E,NONTOXIC-NONHEMAGGLUTININ COMPONENT,NTNH (Clostridiumbotulinum) |
PF01742(Peptidase_M27)PF07953(Toxin_R_bind_N)PF08470(NTNH_C) | 4 | THR B 695LEU B 696THR B 691LEU B 671 | None | 0.88A | 4z91F-4zktB:3.64z91G-4zktB:3.54z91H-4zktB:4.44z91I-4zktB:3.54z91J-4zktB:4.4 | 4z91F-4zktB:15.484z91G-4zktB:15.484z91H-4zktB:15.484z91I-4zktB:15.484z91J-4zktB:15.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dld | UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE (Burkholderiavietnamiensis) |
PF02350(Epimerase_2) | 4 | THR A 73LEU A 76THR A 98LEU A 101 | NoneNoneUD1 A 502 (-4.2A)None | 0.96A | 4z91F-5dldA:undetectable4z91G-5dldA:undetectable4z91H-5dldA:undetectable4z91I-5dldA:undetectable4z91J-5dldA:undetectable | 4z91F-5dldA:22.834z91G-5dldA:22.834z91H-5dldA:22.834z91I-5dldA:22.834z91J-5dldA:22.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5du9 | CDA PEPTIDESYNTHETASE I (Streptomycescoelicolor) |
PF00668(Condensation) | 4 | THR A 12LEU A 11THR A 193THR A 61 | None | 0.89A | 4z91F-5du9A:undetectable4z91G-5du9A:undetectable4z91H-5du9A:undetectable4z91I-5du9A:undetectable4z91J-5du9A:undetectable | 4z91F-5du9A:20.864z91G-5du9A:20.864z91H-5du9A:20.864z91I-5du9A:20.864z91J-5du9A:20.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5du9 | CDA PEPTIDESYNTHETASE I (Streptomycescoelicolor) |
PF00668(Condensation) | 4 | THR A 61THR A 12LEU A 11THR A 193 | None | 0.90A | 4z91F-5du9A:undetectable4z91G-5du9A:undetectable4z91H-5du9A:undetectable4z91I-5du9A:undetectable4z91J-5du9A:undetectable | 4z91F-5du9A:20.864z91G-5du9A:20.864z91H-5du9A:20.864z91I-5du9A:20.864z91J-5du9A:20.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eq6 | TYPE 4 FIMBRIALBIOGENESIS PROTEINPILM (Pseudomonasaeruginosa) |
PF11104(PilM_2) | 4 | THR A 206LEU A 207THR A 215THR A 218 | None | 0.90A | 4z91F-5eq6A:undetectable4z91G-5eq6A:undetectable4z91H-5eq6A:undetectable4z91I-5eq6A:undetectable4z91J-5eq6A:undetectable | 4z91F-5eq6A:20.954z91G-5eq6A:20.954z91H-5eq6A:20.954z91I-5eq6A:20.954z91J-5eq6A:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eq6 | TYPE 4 FIMBRIALBIOGENESIS PROTEINPILM (Pseudomonasaeruginosa) |
PF11104(PilM_2) | 4 | THR A 215THR A 218THR A 206LEU A 207 | None | 0.91A | 4z91F-5eq6A:undetectable4z91G-5eq6A:undetectable4z91H-5eq6A:undetectable4z91I-5eq6A:undetectable4z91J-5eq6A:undetectable | 4z91F-5eq6A:20.954z91G-5eq6A:20.954z91H-5eq6A:20.954z91I-5eq6A:20.954z91J-5eq6A:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7s | GLYCOSIDE HYDROLASEFAMILY 31 (Trueperellapyogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 4 | THR A 274LEU A 277THR A 646LEU A 556 | None | 0.96A | 4z91F-5f7sA:1.54z91G-5f7sA:1.44z91H-5f7sA:1.44z91I-5f7sA:1.54z91J-5f7sA:1.5 | 4z91F-5f7sA:18.044z91G-5f7sA:18.044z91H-5f7sA:18.044z91I-5f7sA:18.044z91J-5f7sA:18.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h6j | PIERISIN-1 (Pieris rapae) |
no annotation | 4 | LEU A 53THR A 56THR A 118LEU A 68 | None | 0.93A | 4z91F-5h6jA:undetectable4z91G-5h6jA:undetectable4z91H-5h6jA:undetectable4z91I-5h6jA:undetectable4z91J-5h6jA:undetectable | 4z91F-5h6jA:21.214z91G-5h6jA:21.214z91H-5h6jA:21.214z91I-5h6jA:21.214z91J-5h6jA:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j9g | GLYCERALDEHYDE-3-PDEHYDROGENASE (Lactobacillusacidophilus) |
PF00044(Gp_dh_N)PF02800(Gp_dh_C) | 4 | THR A 157LEU A 161THR A 216THR A 248 | None | 0.89A | 4z91F-5j9gA:undetectable4z91G-5j9gA:undetectable4z91H-5j9gA:undetectable4z91I-5j9gA:undetectable4z91J-5j9gA:undetectable | 4z91F-5j9gA:21.294z91G-5j9gA:21.294z91H-5j9gA:21.294z91I-5j9gA:21.294z91J-5j9gA:21.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j9g | GLYCERALDEHYDE-3-PDEHYDROGENASE (Lactobacillusacidophilus) |
PF00044(Gp_dh_N)PF02800(Gp_dh_C) | 4 | THR A 248THR A 157LEU A 161THR A 216 | None | 0.95A | 4z91F-5j9gA:undetectable4z91G-5j9gA:undetectable4z91H-5j9gA:undetectable4z91I-5j9gA:undetectable4z91J-5j9gA:undetectable | 4z91F-5j9gA:21.294z91G-5j9gA:21.294z91H-5j9gA:21.294z91I-5j9gA:21.294z91J-5j9gA:21.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jp5 | GALECTIN-5 (Rattusnorvegicus) |
PF00337(Gal-bind_lectin) | 4 | LEU A 140THR A 145THR A 19LEU A 132 | None | 0.85A | 4z91F-5jp5A:undetectable4z91G-5jp5A:undetectable4z91H-5jp5A:undetectable4z91I-5jp5A:undetectable4z91J-5jp5A:undetectable | 4z91F-5jp5A:19.314z91G-5jp5A:19.314z91H-5jp5A:19.314z91I-5jp5A:19.314z91J-5jp5A:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lc5 | NADH-UBIQUINONEOXIDOREDUCTASE CHAIN2NADH-UBIQUINONEOXIDOREDUCTASE CHAIN4 (Bos taurus) |
PF00361(Proton_antipo_M)PF01059(Oxidored_q5_N)PF06444(NADH_dehy_S2_C) | 4 | LEU M 147THR M 134THR N 301THR N 297 | None | 0.89A | 4z91F-5lc5M:undetectable4z91G-5lc5M:undetectable4z91H-5lc5M:undetectable4z91I-5lc5M:undetectable4z91J-5lc5M:undetectable | 4z91F-5lc5M:21.554z91G-5lc5M:21.554z91H-5lc5M:21.554z91I-5lc5M:21.554z91J-5lc5M:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lc5 | NADH-UBIQUINONEOXIDOREDUCTASE CHAIN2NADH-UBIQUINONEOXIDOREDUCTASE CHAIN4 (Bos taurus) |
PF00361(Proton_antipo_M)PF01059(Oxidored_q5_N)PF06444(NADH_dehy_S2_C) | 4 | THR N 301THR N 297LEU M 147THR M 134 | None | 0.96A | 4z91F-5lc5N:undetectable4z91G-5lc5N:undetectable4z91H-5lc5N:undetectable4z91I-5lc5N:undetectable4z91J-5lc5N:undetectable | 4z91F-5lc5N:21.144z91G-5lc5N:21.144z91H-5lc5N:21.144z91I-5lc5N:21.144z91J-5lc5N:21.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lc5 | NADH-UBIQUINONEOXIDOREDUCTASE CHAIN4 (Bos taurus) |
PF00361(Proton_antipo_M)PF01059(Oxidored_q5_N) | 4 | THR M 129LEU M 130THR M 153LEU M 154 | None | 0.74A | 4z91F-5lc5M:undetectable4z91G-5lc5M:undetectable4z91H-5lc5M:undetectable4z91I-5lc5M:undetectable4z91J-5lc5M:undetectable | 4z91F-5lc5M:21.554z91G-5lc5M:21.554z91H-5lc5M:21.554z91I-5lc5M:21.554z91J-5lc5M:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lnk | MITOCHONDRIALCOMPLEX I, ND5SUBUNIT (Ovis aries) |
PF00361(Proton_antipo_M)PF00662(Proton_antipo_N)PF06455(NADH5_C) | 4 | THR L 412LEU L 413THR L 401LEU L 486 | None | 0.78A | 4z91F-5lnkL:undetectable4z91G-5lnkL:undetectable4z91H-5lnkL:undetectable4z91I-5lnkL:undetectable4z91J-5lnkL:undetectable | 4z91F-5lnkL:19.244z91G-5lnkL:19.244z91H-5lnkL:19.244z91I-5lnkL:19.244z91J-5lnkL:19.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsp | HEPATOCYTE GROWTHFACTOR RECEPTOR (Homo sapiens) |
PF01437(PSI)PF01833(TIG) | 4 | THR A 613LEU A 612THR A 582THR A 621 | None | 0.96A | 4z91F-5lspA:undetectable4z91G-5lspA:undetectable4z91H-5lspA:undetectable4z91I-5lspA:undetectable4z91J-5lspA:undetectable | 4z91F-5lspA:19.884z91G-5lspA:19.884z91H-5lspA:19.884z91I-5lspA:19.884z91J-5lspA:19.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u2o | J30 CCH (Thermobacilluscomposti) |
no annotation | 5 | THR A 456LEU A 481THR A 476THR A 107LEU A 109 | None | 1.32A | 4z91F-5u2oA:2.04z91G-5u2oA:2.14z91H-5u2oA:2.04z91I-5u2oA:1.94z91J-5u2oA:1.8 | 4z91F-5u2oA:12.424z91G-5u2oA:12.424z91H-5u2oA:12.424z91I-5u2oA:12.424z91J-5u2oA:12.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vmk | BIFUNCTIONAL PROTEINGLMU (Acinetobacterbaumannii) |
PF00132(Hexapep)PF12804(NTP_transf_3)PF14602(Hexapep_2) | 4 | LEU A 99THR A 167THR A 110LEU A 114 | None | 0.88A | 4z91F-5vmkA:undetectable4z91G-5vmkA:undetectable4z91H-5vmkA:undetectable4z91I-5vmkA:undetectable4z91J-5vmkA:undetectable | 4z91F-5vmkA:21.604z91G-5vmkA:21.604z91H-5vmkA:21.604z91I-5vmkA:21.604z91J-5vmkA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w4a | P-GRANULE SCAFFOLD (Caenorhabditisjaponica) |
no annotation | 4 | THR A 73THR A 80LEU A 81THR A 76 | NoneNoneNoneEDO A 304 (-3.4A) | 0.96A | 4z91F-5w4aA:undetectable4z91G-5w4aA:undetectable4z91H-5w4aA:undetectable4z91I-5w4aA:undetectable4z91J-5w4aA:undetectable | 4z91F-5w4aA:12.774z91G-5w4aA:12.774z91H-5w4aA:12.774z91I-5w4aA:12.774z91J-5w4aA:12.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w95 | CONSERVED MEMBRANEPROTEIN OFUNCHARACTERISEDFUNCTION (Mycobacteriumtuberculosis) |
no annotation | 4 | THR A 231LEU A 232THR A 286LEU A 290 | None1PE A 401 ( 4.9A)None1PE A 401 (-4.4A) | 0.95A | 4z91F-5w95A:undetectable4z91G-5w95A:undetectable4z91H-5w95A:undetectable4z91I-5w95A:undetectable4z91J-5w95A:undetectable | 4z91F-5w95A:12.304z91G-5w95A:12.304z91H-5w95A:12.304z91I-5w95A:12.304z91J-5w95A:12.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wfc | HISTONE-LYSINE-N-METHYLTRANSFERASE EZH2,POLYCOMB PROTEINSUZ12 CHIMERA (Chaetomiumthermophilum) |
no annotation | 5 | THR B 504LEU B 532THR B 604LEU B 542THR B2656 | None | 1.21A | 4z91F-5wfcB:undetectable4z91G-5wfcB:undetectable4z91H-5wfcB:undetectable4z91I-5wfcB:undetectable4z91J-5wfcB:undetectable | 4z91F-5wfcB:12.704z91G-5wfcB:12.704z91H-5wfcB:12.704z91I-5wfcB:12.704z91J-5wfcB:12.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wfc | HISTONE-LYSINE-N-METHYLTRANSFERASE EZH2,POLYCOMB PROTEINSUZ12 CHIMERA (Chaetomiumthermophilum) |
no annotation | 4 | THR B 604THR B2656THR B 504LEU B 532 | None | 0.79A | 4z91F-5wfcB:undetectable4z91G-5wfcB:undetectable4z91H-5wfcB:undetectable4z91I-5wfcB:undetectable4z91J-5wfcB:undetectable | 4z91F-5wfcB:12.704z91G-5wfcB:12.704z91H-5wfcB:12.704z91I-5wfcB:12.704z91J-5wfcB:12.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z97 | LACTONASE FORPROTEIN (Rhinocladiellamackenziei) |
no annotation | 4 | THR A 74THR A 12THR A 89LEU A 90 | None | 0.94A | 4z91F-5z97A:undetectable4z91G-5z97A:undetectable4z91H-5z97A:undetectable4z91I-5z97A:undetectable4z91J-5z97A:undetectable | 4z91F-5z97A:14.554z91G-5z97A:14.554z91H-5z97A:14.554z91I-5z97A:14.554z91J-5z97A:14.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6avf | HLA CLASS IHISTOCOMPATIBILITYANTIGEN, B-7 ALPHACHAIN (Homo sapiens) |
no annotation | 4 | THR H 214LEU H 215LEU H 272THR H 216 | None | 0.85A | 4z91F-6avfH:undetectable4z91G-6avfH:undetectable4z91H-6avfH:undetectable4z91I-6avfH:undetectable4z91J-6avfH:undetectable | 4z91F-6avfH:13.034z91G-6avfH:13.034z91H-6avfH:13.034z91I-6avfH:13.034z91J-6avfH:13.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6exv | DNA-DIRECTED RNAPOLYMERASE IISUBUNIT RPB2 (Sus scrofa) |
no annotation | 5 | THR B 888LEU B 873THR B 836THR B 870THR B 872 | None | 1.41A | 4z91F-6exvB:1.44z91G-6exvB:1.54z91H-6exvB:1.44z91I-6exvB:1.54z91J-6exvB:1.5 | 4z91F-6exvB:11.494z91G-6exvB:11.494z91H-6exvB:11.494z91I-6exvB:11.494z91J-6exvB:11.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6g2j | NADH-UBIQUINONEOXIDOREDUCTASE CHAIN4 (Mus musculus) |
no annotation | 4 | LEU M 150THR M 129THR M 125THR M 153 | None | 0.87A | 4z91F-6g2jM:undetectable4z91G-6g2jM:undetectable4z91H-6g2jM:undetectable4z91I-6g2jM:undetectable4z91J-6g2jM:undetectable | 4z91F-6g2jM:13.104z91G-6g2jM:13.104z91H-6g2jM:13.104z91I-6g2jM:13.104z91J-6g2jM:13.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6g2j | NADH-UBIQUINONEOXIDOREDUCTASE CHAIN4 (Mus musculus) |
no annotation | 4 | THR M 125THR M 153LEU M 150THR M 129 | None | 0.76A | 4z91F-6g2jM:undetectable4z91G-6g2jM:undetectable4z91H-6g2jM:undetectable4z91I-6g2jM:undetectable4z91J-6g2jM:undetectable | 4z91F-6g2jM:13.104z91G-6g2jM:13.104z91H-6g2jM:13.104z91I-6g2jM:13.104z91J-6g2jM:13.10 |